140 related articles for article (PubMed ID: 11239763)
1. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer.
Nakama H; Zhang B; Zhang X
Eur J Cancer; 2001 Feb; 37(3):398-401. PubMed ID: 11239763
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme.
Itoh M; Takahashi K; Nishida H; Sakagami K; Okubo T
J Med Screen; 1996; 3(2):66-71. PubMed ID: 8849762
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
4. Age-related cancer detection rate and costs for one cancer detected in one screening by immunochemical fecal occult blood test.
Nakama H; Zhang B; Zhang X; Fukazawa K
Dis Colon Rectum; 2001 Nov; 44(11):1696-9. PubMed ID: 11711744
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of cancer detection rate and costs of one cancer detected among different age-cohorts in immunochemical occult blood screening.
Nakama H; Zhang B; Fukazawa K; Zhang X
J Cancer Res Clin Oncol; 2001 Jul; 127(7):439-43. PubMed ID: 11469681
[TBL] [Abstract][Full Text] [Related]
7. A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer.
Nakama H; Zhang B; Fattah AS
Eur J Cancer; 2000 Mar; 36(5):647-50. PubMed ID: 10738130
[TBL] [Abstract][Full Text] [Related]
8. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test.
Fenocchi E; Martínez L; Tolve J; Montano D; Rondán M; Parra-Blanco A; Eishi Y
Eur J Cancer Prev; 2006 Oct; 15(5):384-90. PubMed ID: 16912566
[TBL] [Abstract][Full Text] [Related]
10. Improvements in colorectal cancer screening programmes - quantitative immunochemical faecal occult blood testing - how to set the cut-off for a particular population.
Kovarova JT; Zavoral M; Zima T; Zak A; Kocna P; Kohout P; Granatova J; Vanickova Z; Vranova J; Suchanek S; Benes Z; Celko MA; Povysil C
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):143-50. PubMed ID: 22837135
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
Yamamoto M; Nakama H
Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.
Berchi C; Guittet L; Bouvier V; Launoy G
Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of immunochemical tests for colorectal cancer screening.
Lejeune C; Le Gleut K; Cottet V; Galimard C; Durand G; Dancourt V; Faivre J
Dig Liver Dis; 2014 Jan; 46(1):76-81. PubMed ID: 24012177
[TBL] [Abstract][Full Text] [Related]
14. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
[TBL] [Abstract][Full Text] [Related]
15. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population.
Launoy GD; Bertrand HJ; Berchi C; Talbourdet VY; Guizard AV; Bouvier VM; Caces ER
Int J Cancer; 2005 Jun; 115(3):493-6. PubMed ID: 15700317
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
18. The optimal cut-off value in fit-based colorectal cancer screening: An observational study.
Njor SH; Andersen B; Friis-Hansen L; de Haas N; Linnemann D; Nørgaard H; Roikjaer O; Søndergaard B; Rasmussen M
Cancer Med; 2021 Mar; 10(5):1872-1879. PubMed ID: 33534955
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.
Goede SL; van Roon AH; Reijerink JC; van Vuuren AJ; Lansdorp-Vogelaar I; Habbema JD; Kuipers EJ; van Leerdam ME; van Ballegooijen M
Gut; 2013 May; 62(5):727-34. PubMed ID: 22490518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
